Objective To investigate the effect of nonstructural protein 5A ( NS5A) encoded by the human hepatitis C virus ( HCV) RNA genome on human immunodeficiency virus ( HIV) long terminal repeat ( LTR) and to provide an experimental basis for the study on the effect of HCV on HIV. Methods Hepatocellular carcinoma Huh7 cells were divided into blank group, control group, and experimental group to be transfected with plasmid pGL3- LTR- Luc ( containing luciferase reporter gene driven by the LTR promoter) , plasmid pRc / CMV plus plasmid pGL3- LTR- Luc, and plasmid pCNS5A ( containing HCV NS5A gene) plus plasmid pGL3- LTR- Luc, respectively; Huh7 cells were collected 48 h later. The protein and mRNA expression levels of HCV NS5A were measured by immunocytochemistry, Western blot, and RT- PCR. The relative luciferase activity was measured to evaluate the HIV LTR activity and the effect of HCV NS5A on HIV LTR. The activity values were expressed as mean ± SD, and Levene' s test of homogeneity of variance was used; comparison between all groups was made by one- way analysis of variance ( ANOVA) , and comparison between two groups was made by least significant difference ( LSD) test. Results The mRNA and protein expression of HCV NS5A was detected in the cytoplasm of Huh7 cells in experimental group. The one- way ANOVA showed that there were significant differences in LTR luciferase activity between the three groups ( F = 7. 876, P = 0. 002) . The LSD test showed that the experimental group had a significantly higher relative luciferase activity than the blank group and control group ( 22476 ± 4471 vs 15887 ± 3039, P = 0. 002; 22476 ± 4471 vs 16321 ± 4162, P = 0. 008) . Conclusion Huh7 cells can be transfected with the HCV NS5A expression plasmid ( pCNS5A) . HCV NS5A can activate HIV LTR, which suggests that HCV NS5A may be one of the molecular mechanisms of HCV promoting HIV replication.
[1]SUN HQ, HUANG Q, CAI WP, et al.Mutual effects of human immunodeficiency virus and hepatitis C virus on disease progression[J].J Med Res, 2012, 41 (3) :3-5, 86. (in Chinese) 孙洪清, 黄琴, 蔡卫平, 等.人类免疫缺陷病毒和丙型肝炎病毒合并感染对疾病进程的相互影响[J].医学研究, 2012, 41 (3) :3-5, 86.
|
[2]KOZIEL MJ, PETERS MG.Viral hepatitis in HIV infection[J].N Engl J Med, 2007, 356 (14) :1445-1454.
|
[3]ALTER MJ.Epidemiology of viral hepatitis and HIV coinfection[J].J Hepatol, 2006, 44 (1 Suppl) :s6-s9.
|
[4]KOIKE K, TSUKADA K, YOTSUYANAGI K.Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan[J].Hepatol Res, 2007, 37 (1) :2-5.
|
[5]PALELLA FJ JR, DELANEY KM, MOORMAN AC, et al.Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection[J].N Engl J Med, 1998, 338 (13) :853-860.
|
[6]BENHAMOU Y, DI MARTINO V, BOCHET M, et al.Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus coinfected patients:impact of protease inhibitor therapy[J].Hepatology, 2001, 34 (2) :283-287.
|
[7]LIMKETKAI BN, MEHTA SH, SUTCLIFFE CG, et al.Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV[J].JAMA, 2012, 308 (4) :370-378.
|
[8]IMBERT B, RATZIU V, PEIRONI L.Biochemical markers of live fibrosisin patients with hepatitis C virus infection:a respective study[J].Lancet, 2001, 357 (9262) :1069-1075.
|
[9]WU X, ISHAQ M, HU J, et al.HCV NS3/4A protein activates HIV-1transcription from its long terminal repeat[J].Virus Res, 2008, 135 (1) :155-160.
|
[10]TANIMOTO A, IDE Y, ARIMA N, et al.The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast[J].Biochem Biophys Res Commun, 1997, 236 (2) :360-364.
|
[11]SCHIAPPA DA, MITTAL C, BROWN JA, et al.Relationship of hepatitis C genotype l NS5A sequence mutations to early phase viral kinetics and interferon effectiveness[J].J Infect Dis, 2002, 185 (7) :868-877.
|
[12]GHOSH AK, MAJUMDER M, STEELE R, et al.Hepatitis C virus NSSA protects against TNF-alpha mediated apoptotic cell death[J].Virus Res, 2000, 67 (2) :173-178.
|
[13]ZHOU Y, GONG GZ.Hepatitis C virus NS5A protein upregulates surviving gene expression[J].Chin J Hepatol, 2006, 14 (6) :414-417. (in Chinese) 周泱, 龚国忠.HCVNS5A对Survivin基因表达的影响[J].中华肝脏病杂志, 2006, 14 (6) :414-417.
|
[14]CAO J, ZHOU Y, GONG GZ.Effect of HCV NS5A on STAT-1phosphorylation and nuclear transloeation induced by IFNα-2b[J].Chin J Hepatol, 2006, 14 (12) :894-897. (in Chinese) 曹婕, 周泱, 龚国忠.HCV NS5A对干扰素诱导STAT-1信号影响[J].中华肝脏病杂志, 2006, 14 (12) :894-897.
|
[15]GONG G, WARIS G, TANVEER R, et al.Human hepatitis C virus NSSA protein alters intracellular calcium level, induces ocidative stress, and activates STAT-3 and NF-kB[J].Proe Natl Acad Sci U S A, 2001, 98 (17) :9599-9604.
|
[16]DANDEKAR DH, GANESH KN, MITRA D.HIV-1 Tat directly binds to NFkappaB enhancer sequence:role in viral and cellular gene expression[J].Nucleic Acids Res, 2004, 32 (4) :1270-1278.
|
[17]KANG WZ, HUANG DD, LI Y, et al.HIV-specifi c cytotoxic T-lymphocyte responses in patients co-infected with HIV and HCV[J].J Clin Hepatol, 2011, 27 (1) :68-80. (in Chinese) 康文臻, 黄德东, 李媛, 等.艾滋病病毒/丙型肝炎病毒双重感染者的艾滋病病毒特异性CTL应答[J].临床肝胆病杂志, 2011, 27 (1) :68-80.
|
[18]KANG L, LUO Z, LI Y, et al.Association of Vpu with hepatitis C virus NS3/4A stimulates transcription of type 1 human immunodeficiency virus[J].Virus Res, 2012, 163 (1) :74-81.
|